Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

Reconciling fast Hepatitis B evolutionary rates with ancient co-divergence

Preprint Created on 09 Jun 2026 bioRxiv

Estimating evolutionary rates and divergence times for hepatitis B virus (HBV) has long been complicated by conflicting calibration approaches and extensive rate variation. To unlock the full potential of ancient and modern HBV genomic data, we develop a Bayesian mixed-effects molecular clock model that accounts for various sources of rate variation including time-dependent rate decay. Our analyses reveal a pronounced decline in evolutionary rates over time, reconciling HBV divergence estimates with human migration events across both deep and more recent timescales. We show that HBV spread into Europe through both Neolithic farming expansions and later steppe migrations, paralleling patterns proposed for Indo-European language origins. Phylogeographic reconstructions suggest that the Neolithic-associated lineage dispersed at approximately 1 km/year, consistent with archaeological estimates, while genotype D expanded during the Bronze Age at an almost threefold higher rate, plausibly driven by technological innovations underlying steppe expansions. Historical overlap between these lineages facilitated recombination, giving rise to genotype E, which has become a dominant HBV genotype in Africa. These findings demonstrate that ancient viral genomes, when analyzed with models capturing complex rate dynamics, provide a powerful lens on human prehistory and the processes shaping pathogen diversity.

Lemey, P., Ji, X., Vrancken, B., Bletsa, M., Datta, P., Kafetzopoulou, L. E., Mifsud, J., Baele, G., Pourkarim, M. R., Patrono, L., Calvignac-Spencer, S., Orlando, L., Bastide, P., Guindon, S., Martin, D., Suchard, M. A.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement